| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |